{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:07:59Z","timestamp":1794269279331,"version":"4.9.0"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2011,7,27]],"date-time":"2011-07-27T00:00:00Z","timestamp":1311724800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1038\/npp.2011.128","type":"journal-article","created":{"date-parts":[[2011,7,27]],"date-time":"2011-07-27T14:10:04Z","timestamp":1311775804000},"page":"2406-2421","source":"Crossref","is-referenced-by-count":121,"title":["Combined Treatment with the Mood Stabilizers Lithium and Valproate Produces Multiple Beneficial Effects in Transgenic Mouse Models of Huntington's Disease"],"prefix":"10.1038","volume":"36","author":[{"given":"Chi-Tso","family":"Chiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Leeds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-Maw","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,7,27]]},"reference":[{"key":"BFnpp2011128_CR1","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1073\/pnas.0711496105","volume":"105","author":"JM Beaulieu","year":"2008","unstructured":"Beaulieu JM, Zhang X, Rodriguiz RM, Sotnikova TD, Cools MJ, Wetsel WC et al (2008). Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency. Proc Natl Acad Sci USA 105: 1333\u20131338.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp2011128_CR2","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1089\/10430349950016393","volume":"10","author":"AP Bemelmans","year":"1999","unstructured":"Bemelmans AP, Horellou P, Pradier L, Brunet I, Colin P, Mallet J (1999). Brain-derived neurotrophic factor-mediated protection of striatal neurons in an excitotoxic rat model of Huntington's disease, as demonstrated by adenoviral gene transfer. Hum Gene Ther 10: 2987\u20132997.","journal-title":"Hum Gene Ther"},{"key":"BFnpp2011128_CR3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/FBP.0b013e32801416ed","volume":"18","author":"Y Bersudsky","year":"2007","unstructured":"Bersudsky Y, Shaldubina A, Belmaker RH (2007). Lithium's effect in forced-swim test is blood level dependent but not dependent on weight loss. Behav Pharmacol 18: 77\u201380.","journal-title":"Behav Pharmacol"},{"key":"BFnpp2011128_CR4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.it.2009.09.007","volume":"31","author":"E Beurel","year":"2010","unstructured":"Beurel E, Michalek SM, Jope RS (2010). Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3). Trends Immunol 31: 24\u201331.","journal-title":"Trends Immunol"},{"key":"BFnpp2011128_CR5","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.nlm.2004.01.001","volume":"81","author":"MM Buitrago","year":"2004","unstructured":"Buitrago MM, Schulz JB, Dichgans J, Luft AR (2004). Short and long-term motor skill learning in an accelerated rotarod training paradigm. Neurobiol Learn Mem 81: 211\u2013216.","journal-title":"Neurobiol Learn Mem"},{"key":"BFnpp2011128_CR6","doi-asserted-by":"crossref","first-page":"7727","DOI":"10.1523\/JNEUROSCI.1197-04.2004","volume":"24","author":"JM Canals","year":"2004","unstructured":"Canals JM, Pineda JR, Torres-Peraza JF, Bosch M, Martin-Ibanez R, Munoz MT et al (2004). Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease. J Neurosci 24: 7727\u20137739.","journal-title":"J Neurosci"},{"key":"BFnpp2011128_CR7","doi-asserted-by":"crossref","first-page":"33791","DOI":"10.1074\/jbc.M204861200","volume":"277","author":"J Carmichael","year":"2002","unstructured":"Carmichael J, Sugars KL, Bao YP, Rubinsztein DC (2002). Glycogen synthase kinase-3beta inhibitors prevent cellular polyglutamine toxicity caused by the Huntington's disease mutation. J Biol Chem 277: 33791\u201333798.","journal-title":"J Biol Chem"},{"key":"BFnpp2011128_CR8","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","volume":"19","author":"RJ Carter","year":"1999","unstructured":"Carter RJ, Lione LA, Humby T, Mangiarini L, Mahal A, Bates GP et al (1999). Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J Neurosci 19: 3248\u20133257.","journal-title":"J Neurosci"},{"key":"BFnpp2011128_CR9","doi-asserted-by":"crossref","first-page":"8745","DOI":"10.1073\/pnas.96.15.8745","volume":"96","author":"E Chalecka-Franaszek","year":"1999","unstructured":"Chalecka-Franaszek E, Chuang DM (1999). Lithium activates the serine\/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons. Proc Natl Acad Sci USA 96: 8745\u20138750.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp2011128_CR10","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1093\/hmg\/9.19.2811","volume":"9","author":"HY Chan","year":"2000","unstructured":"Chan HY, Warrick JM, Gray-Board GL, Paulson HL, Bonini NM (2000). Mechanisms of chaperone suppression of polyglutamine disease: selectivity, synergy and modulation of protein solubility in Drosophila. Hum Mol Genet 9: 2811\u20132820.","journal-title":"Hum Mol Genet"},{"key":"BFnpp2011128_CR11","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1046\/j.1471-4159.2000.0721327.x","volume":"72","author":"G Chen","year":"1999","unstructured":"Chen G, Huang LD, Jiang YM, Manji HK (1999). The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3. J Neurochem 72: 1327\u20131330.","journal-title":"J Neurochem"},{"key":"BFnpp2011128_CR12","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/hmg\/ddl481","volume":"16","author":"MC Chiang","year":"2007","unstructured":"Chiang MC, Chen HM, Lee YH, Chang HH, Wu YC, Soong BW et al (2007). Dysregulation of C\/EBPalpha by mutant Huntingtin causes the urea cycle deficiency in Huntington's disease. Hum Mol Genet 16: 483\u2013498.","journal-title":"Hum Mol Genet"},{"key":"BFnpp2011128_CR13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.pharmthera.2010.07.006","volume":"128","author":"CT Chiu","year":"2010","unstructured":"Chiu CT, Chuang DM (2010). Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders. Pharmacol Ther 128: 281\u2013304.","journal-title":"Pharmacol Ther"},{"key":"BFnpp2011128_CR14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1196\/annals.1344.018","volume":"1053","author":"DM Chuang","year":"2005","unstructured":"Chuang DM (2005). The antiapoptotic actions of mood stabilizers: molecular mechanisms and therapeutic potentials. Ann NY Acad Sci 1053: 195\u2013204.","journal-title":"Ann NY Acad Sci"},{"key":"BFnpp2011128_CR15","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.tins.2009.06.002","volume":"32","author":"DM Chuang","year":"2009","unstructured":"Chuang DM, Leng Y, Marinova Z, Kim HJ, Chiu CT (2009). Multiple roles of HDAC inhibition in neurodegenerative conditions. Trends Neurosci 32: 591\u2013601.","journal-title":"Trends Neurosci"},{"key":"BFnpp2011128_CR16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0149-7634(85)90030-2","volume":"9","author":"JN Crawley","year":"1985","unstructured":"Crawley JN (1985). Exploratory behavior models of anxiety in mice. Neurosci Biobehav Rev 9: 37\u201344.","journal-title":"Neurosci Biobehav Rev"},{"key":"BFnpp2011128_CR17","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/sj.mp.4001457","volume":"9","author":"JF Cryan","year":"2004","unstructured":"Cryan JF, Mombereau C (2004). In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice. Mol Psychiatry 9: 326\u2013357.","journal-title":"Mol Psychiatry"},{"key":"BFnpp2011128_CR18","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.neubiorev.2005.03.009","volume":"29","author":"JF Cryan","year":"2005","unstructured":"Cryan JF, Mombereau C, Vassout A (2005). The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev 29: 571\u2013625.","journal-title":"Neurosci Biobehav Rev"},{"key":"BFnpp2011128_CR19","first-page":"767","volume":"14","author":"L de Angelis","year":"1992","unstructured":"de Angelis L (1992). The anxiogenic-like effects of pentylenetetrazole in mice treated chronically with carbamazepine or valproate. Methods Find Exp Clin Pharmacol 14: 767\u2013771.","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"BFnpp2011128_CR20","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/S0028-3908(02)00215-0","volume":"43","author":"P De Sarno","year":"2002","unstructured":"De Sarno P, Li X, Jope RS (2002). Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium. Neuropharmacology 43: 1158\u20131164.","journal-title":"Neuropharmacology"},{"key":"BFnpp2011128_CR21","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1136\/jmg.30.4.293","volume":"30","author":"ML Di","year":"1993","unstructured":"Di ML, Squitieri F, Napolitano G, Campanella G, Trofatter JA, Conneally PM (1993). Suicide risk in Huntington's disease. J Med Genet 30: 293\u2013295.","journal-title":"J Med Genet"},{"key":"BFnpp2011128_CR22","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1073\/pnas.0536856100","volume":"100","author":"W Duan","year":"2003","unstructured":"Duan W, Guo Z, Jiang H, Ware M, Li XJ, Mattson MP (2003). Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice. Proc Natl Acad Sci USA 100: 2911\u20132916.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp2011128_CR23","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.nbd.2008.01.015","volume":"30","author":"W Duan","year":"2008","unstructured":"Duan W, Peng Q, Masuda N, Ford E, Tryggestad E, Ladenheim B et al (2008). Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington's disease. Neurobiol Dis 30: 312\u2013322.","journal-title":"Neurobiol Dis"},{"key":"BFnpp2011128_CR24","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.neuroscience.2008.06.040","volume":"155","author":"HL Feng","year":"2008","unstructured":"Feng HL, Leng Y, Ma CH, Zhang J, Ren M, Chuang DM (2008). Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model. Neuroscience 155: 567\u2013572.","journal-title":"Neuroscience"},{"key":"BFnpp2011128_CR25","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0006-8993(00)02237-X","volume":"866","author":"I Ferrer","year":"2000","unstructured":"Ferrer I, Goutan E, Marin C, Rey MJ, Ribalta T (2000). Brain-derived neurotrophic factor in Huntington disease. Brain Res 866: 257\u2013261.","journal-title":"Brain Res"},{"key":"BFnpp2011128_CR26","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0006-8993(98)00736-7","volume":"805","author":"SE File","year":"1998","unstructured":"File SE, Mahal A, Mangiarini L, Bates GP (1998). Striking changes in anxiety in Huntington's disease transgenic mice. Brain Res 805: 234\u2013240.","journal-title":"Brain Res"},{"key":"BFnpp2011128_CR27","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1152\/physrev.1999.79.2.425","volume":"79","author":"AL Fink","year":"1999","unstructured":"Fink AL (1999). Chaperone-mediated protein folding. Physiol Rev 79: 425\u2013449.","journal-title":"Physiol Rev"},{"key":"BFnpp2011128_CR28","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1056\/NEJMra022366","volume":"348","author":"RM Friedlander","year":"2003","unstructured":"Friedlander RM (2003). Apoptosis and caspases in neurodegenerative diseases. N Engl J Med 348: 1365\u20131375.","journal-title":"N Engl J Med"},{"key":"BFnpp2011128_CR29","doi-asserted-by":"crossref","first-page":"34908","DOI":"10.1074\/jbc.M506288200","volume":"280","author":"M Fujimoto","year":"2005","unstructured":"Fujimoto M, Takaki E, Hayashi T, Kitaura Y, Tanaka Y, Inouye S et al (2005). Active HSF1 significantly suppresses polyglutamine aggregate formation in cellular and mouse models. J Biol Chem 280: 34908\u201334916.","journal-title":"J Biol Chem"},{"key":"BFnpp2011128_CR30","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s002130100871","volume":"158","author":"T Fukumoto","year":"2001","unstructured":"Fukumoto T, Morinobu S, Okamoto Y, Kagaya A, Yamawaki S (2001). Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain. Psychopharmacology (Berl) 158: 100\u2013106.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp2011128_CR31","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","volume":"20","author":"M G\u00f6ttlicher","year":"2001","unstructured":"G\u00f6ttlicher M, Minucci S, Zhu P, Kramer OH, Schimpf A, Giavara S et al (2001). Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J 20: 6969\u20136978.","journal-title":"EMBO J"},{"key":"BFnpp2011128_CR32","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/sj.npp.1300283","volume":"29","author":"TD Gould","year":"2004","unstructured":"Gould TD, Chen G, Manji HK (2004). In vivo evidence in the brain for lithium inhibition of glycogen synthase kinase-3. Neuropsychopharmacology 29: 32\u201338.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2011128_CR33","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.neuropharm.2007.11.002","volume":"54","author":"TD Gould","year":"2008","unstructured":"Gould TD, O'Donnell KC, Dow ER, Du J, Chen G, Manji HK (2008). Involvement of AMPA receptors in the antidepressant-like effects of lithium in the mouse tail suspension test and forced swim test. Neuropharmacology 54: 577\u2013587.","journal-title":"Neuropharmacology"},{"key":"BFnpp2011128_CR34","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0301-0082(01)00011-9","volume":"65","author":"CA Grimes","year":"2001","unstructured":"Grimes CA, Jope RS (2001). The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog Neurobiol 65: 391\u2013426.","journal-title":"Prog Neurobiol"},{"key":"BFnpp2011128_CR35","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/1043-4682(95)90011-X","volume":"6","author":"JF Gusella","year":"1995","unstructured":"Gusella JF, MacDonald ME (1995). Huntington's disease. Semin Cell Biol 6: 21\u201328.","journal-title":"Semin Cell Biol"},{"key":"BFnpp2011128_CR36","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/jnnp.74.1.120","volume":"74","author":"JM Hamilton","year":"2003","unstructured":"Hamilton JM, Salmon DP, Corey-Bloom J, Gamst A, Paulsen JS, Jerkins S et al (2003). Behavioural abnormalities contribute to functional decline in Huntington's disease. J Neurol Neurosurg Psychiatry 74: 120\u2013122.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFnpp2011128_CR37","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1126\/science.1068408","volume":"295","author":"FU Hartl","year":"2002","unstructured":"Hartl FU, Hayer-Hartl M (2002). Molecular chaperones in the cytosol: from nascent chain to folded protein. Science 295: 1852\u20131858.","journal-title":"Science"},{"key":"BFnpp2011128_CR38","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0028-3908(02)00217-4","volume":"43","author":"R Hashimoto","year":"2002","unstructured":"Hashimoto R, Takei N, Shimazu K, Christ L, Lu B, Chuang DM (2002). Lithium induces brain-derived neurotrophic factor and activates TrkB in rodent cortical neurons: an essential step for neuroprotection against glutamate excitotoxicity. Neuropharmacology 43: 1173\u20131179.","journal-title":"Neuropharmacology"},{"key":"BFnpp2011128_CR39","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1093\/hmg\/ddh144","volume":"13","author":"DG Hay","year":"2004","unstructured":"Hay DG, Sathasivam K, Tobaben S, Stahl B, Marber M, Mestril R et al (2004). Progressive decrease in chaperone protein levels in a mouse model of Huntington's disease and induction of stress proteins as a therapeutic approach. Hum Mol Genet 13: 1389\u20131405.","journal-title":"Hum Mol Genet"},{"key":"BFnpp2011128_CR40","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0278-5846(03)00021-6","volume":"27","author":"MA Hickey","year":"2003","unstructured":"Hickey MA, Chesselet MF (2003). Apoptosis in Huntington's disease. Prog Neuropsychopharmacol Biol Psychiatry 27: 255\u2013265.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFnpp2011128_CR41","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.neuroscience.2008.08.041","volume":"157","author":"MA Hickey","year":"2008","unstructured":"Hickey MA, Kosmalska A, Enayati J, Cohen R, Zeitlin S, Levine MS et al (2008). Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington's disease mice. Neuroscience 157: 280\u2013295.","journal-title":"Neuroscience"},{"key":"BFnpp2011128_CR42","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/hmg\/ddl013","volume":"15","author":"A Hodges","year":"2006","unstructured":"Hodges A, Strand AD, Aragaki AK, Kuhn A, Sengstag T, Hughes G et al (2006). Regional and cellular gene expression changes in human Huntington's disease brain. Hum Mol Genet 15: 965\u2013977.","journal-title":"Hum Mol Genet"},{"key":"BFnpp2011128_CR43","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.2174\/1389450110607011389","volume":"7","author":"HC Huang","year":"2006","unstructured":"Huang HC, Klein PS (2006). Multiple roles for glycogen synthase kinase-3 as a drug target in Alzheimer's disease. Curr Drug Targets 7: 1389\u20131397.","journal-title":"Curr Drug Targets"},{"key":"BFnpp2011128_CR44","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1093\/hmg\/9.13.2009","volume":"9","author":"NR Jana","year":"2000","unstructured":"Jana NR, Tanaka M, Wang G, Nukina N (2000). Polyglutamine length-dependent interaction of Hsp40 and Hsp70 family chaperones with truncated N-terminal huntingtin: their role in suppression of aggregation and cellular toxicity. Hum Mol Genet 9: 2009\u20132018.","journal-title":"Hum Mol Genet"},{"key":"BFnpp2011128_CR45","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/BF00537801","volume":"259","author":"BJ Jones","year":"1968","unstructured":"Jones BJ, Roberts DJ (1968). A rotarod suitable for quantitative measurements of motor incoordination in naive mice. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol 259: 211.","journal-title":"Naunyn Schmiedebergs Arch Exp Pathol Pharmakol"},{"key":"BFnpp2011128_CR46","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s11064-006-9128-5","volume":"32","author":"RS Jope","year":"2007","unstructured":"Jope RS, Yuskaitis CJ, Beurel E (2007). Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics. Neurochem Res 32: 577\u2013595.","journal-title":"Neurochem Res"},{"key":"BFnpp2011128_CR47","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.biopsych.2004.01.008","volume":"55","author":"O Kaidanovich-Beilin","year":"2004","unstructured":"Kaidanovich-Beilin O, Milman A, Weizman A, Pick CG, Eldar-Finkelman H (2004). Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on beta-catenin in mouse hippocampus. Biol Psychiatry 55: 781\u2013784.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2011128_CR48","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ymthe.2004.02.016","volume":"9","author":"AP Kells","year":"2004","unstructured":"Kells AP, Fong DM, Dragunow M, During MJ, Young D, Connor B (2004). AAV-mediated gene delivery of BDNF or GDNF is neuroprotective in a model of Huntington disease. Mol Ther 9: 682\u2013688.","journal-title":"Mol Ther"},{"key":"BFnpp2011128_CR49","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1124\/jpet.107.120188","volume":"321","author":"HJ Kim","year":"2007","unstructured":"Kim HJ, Rowe M, Ren M, Hong JS, Chen PS, Chuang DM (2007). Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action. J Pharmacol Exp Ther 321: 892\u2013901.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp2011128_CR50","doi-asserted-by":"crossref","first-page":"8455","DOI":"10.1073\/pnas.93.16.8455","volume":"93","author":"PS Klein","year":"1996","unstructured":"Klein PS, Melton DA (1996). A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA 93: 8455\u20138459.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp2011128_CR51","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.bbr.2006.01.003","volume":"169","author":"P Klivenyi","year":"2006","unstructured":"Klivenyi P, Bende Z, Hartai Z, Penke Z, Nemeth H, Toldi J et al (2006). Behaviour changes in a transgenic model of Huntington's disease. Behav Brain Res 169: 137\u2013141.","journal-title":"Behav Brain Res"},{"key":"BFnpp2011128_CR52","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1523\/JNEUROSCI.5467-07.2008","volume":"28","author":"Y Leng","year":"2008","unstructured":"Leng Y, Liang MH, Ren M, Marinova Z, Leeds P, Chuang DM (2008). Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition. J Neurosci 28: 2576\u20132588.","journal-title":"J Neurosci"},{"key":"BFnpp2011128_CR53","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0005-2760(97)00090-8","volume":"1389","author":"YW Liaw","year":"1998","unstructured":"Liaw YW, Liu YW, Chen BK, Chang WC (1998). Induction of 12-lipoxygenase expression by phorbol 12-myristate 13-acetate in human epidermoid carcinoma A431 cells. Biochim Biophys Acta 1389: 23\u201333.","journal-title":"Biochim Biophys Acta"},{"key":"BFnpp2011128_CR54","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"ME MacDonald","year":"1993","unstructured":"MacDonald ME, Ambrose CM, Duyao MP, Myers RH, Lin C, Srinidhi L et al (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72: 971\u2013983.","journal-title":"Cell"},{"key":"BFnpp2011128_CR55","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/j.1471-4159.2009.06385.x","volume":"111","author":"Z Marinova","year":"2009","unstructured":"Marinova Z, Ren M, Wendland JR, Leng Y, Liang MH, Yasuda S et al (2009). Valproic acid induces functional heat-shock protein 70 via class I histone deacetylase inhibition in cortical neurons: a potential role of Sp1 acetylation. J Neurochem 111: 976\u2013987.","journal-title":"J Neurochem"},{"key":"BFnpp2011128_CR56","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1056\/NEJM198611133152006","volume":"315","author":"JB Martin","year":"1986","unstructured":"Martin JB, Gusella JF (1986). Huntington's disease. Pathogenesis and management. N Engl J Med 315: 1267\u20131276.","journal-title":"N Engl J Med"},{"key":"BFnpp2011128_CR57","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.nbd.2009.05.007","volume":"35","author":"L Menalled","year":"2009","unstructured":"Menalled L, El-Khodor BF, Patry M, Suarez-Farinas M, Orenstein SJ, Zahasky B et al (2009). Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models. Neurobiol Dis 35: 319\u2013336.","journal-title":"Neurobiol Dis"},{"key":"BFnpp2011128_CR58","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/ajcn\/50.1.145","volume":"50","author":"LM Morales","year":"1989","unstructured":"Morales LM, Estevez J, Suarez H, Villalobos R, Chacin de BL, Bonilla E (1989). Nutritional evaluation of Huntington disease patients. Am J Clin Nutr 50: 145\u2013150.","journal-title":"Am J Clin Nutr"},{"key":"BFnpp2011128_CR59","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/0165-3806(96)83489-4","volume":"90","author":"N Nakao","year":"1995","unstructured":"Nakao N, Brundin P, Funa K, Lindvall O, Odin P (1995). Trophic and protective actions of brain-derived neurotrophic factor on striatal DARPP-32-containing neurons in vitro. Brain Res Dev Brain Res 90: 92\u2013101.","journal-title":"Brain Res Dev Brain Res"},{"key":"BFnpp2011128_CR60","doi-asserted-by":"crossref","first-page":"6791","DOI":"10.1523\/JNEUROSCI.4753-03.2004","volume":"24","author":"WT O'Brien","year":"2004","unstructured":"O'Brien WT, Harper AD, Jove F, Woodgett JR, Maretto S, Piccolo S et al (2004). Glycogen synthase kinase-3beta haploinsufficiency mimics the behavioral and molecular effects of lithium. J Neurosci 24: 6791\u20136798.","journal-title":"J Neurosci"},{"key":"BFnpp2011128_CR61","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1017\/S1461145710000726","volume":"14","author":"N Omata","year":"2011","unstructured":"Omata N, Chiu CT, Moya PR, Leng Y, Wang Z, Hunsberger JG et al (2011). Lentivirally mediated GSK-3beta silencing in the hippocampal dentate gyrus induces antidepressant-like effects in stressed mice. Int J Neuropsychopharmacol 14: 711\u2013717.","journal-title":"Int J Neuropsychopharmacol"},{"key":"BFnpp2011128_CR62","doi-asserted-by":"crossref","first-page":"36734","DOI":"10.1074\/jbc.M101287200","volume":"276","author":"CJ Phiel","year":"2001","unstructured":"Phiel CJ, Zhang F, Huang EY, Guenther MG, Lazar MA, Klein PS (2001). Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem 276: 36734\u201336741.","journal-title":"J Biol Chem"},{"key":"BFnpp2011128_CR63","first-page":"327","volume":"229","author":"RD Porsolt","year":"1977","unstructured":"Porsolt RD, Bertin A, Jalfre M (1977). Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229: 327\u2013336.","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"BFnpp2011128_CR64","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/brain\/awp006","volume":"132","author":"MA Pouladi","year":"2009","unstructured":"Pouladi MA, Graham RK, Karasinska JM, Xie Y, Santos RD, Petersen A et al (2009). Prevention of depressive behaviour in the YAC128 mouse model of Huntington disease by mutation at residue 586 of huntingtin. Brain 132: 919\u2013932.","journal-title":"Brain"},{"key":"BFnpp2011128_CR65","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/j.1471-4159.2004.02406.x","volume":"89","author":"M Ren","year":"2004","unstructured":"Ren M, Leng Y, Jeong M, Leeds PR, Chuang DM (2004). Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein induction. J Neurochem 89: 1358\u20131367.","journal-title":"J Neurochem"},{"key":"BFnpp2011128_CR66","doi-asserted-by":"crossref","first-page":"6210","DOI":"10.1073\/pnas.0937423100","volume":"100","author":"M Ren","year":"2003","unstructured":"Ren M, Senatorov VV, Chen RW, Chuang DM (2003). Postinsult treatment with lithium reduces brain damage and facilitates neurological recovery in a rat ischemia\/reperfusion model. Proc Natl Acad Sci USA 100: 6210\u20136215.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp2011128_CR67","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.pnpbp.2008.05.020","volume":"32","author":"AO Rosa","year":"2008","unstructured":"Rosa AO, Kaster MP, Binfare RW, Morales S, Martin-Aparicio E, Navarro-Rico ML et al (2008). Antidepressant-like effect of the novel thiadiazolidinone NP031115 in mice. Prog Neuropsychopharmacol Biol Psychiatry 32: 1549\u20131556.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFnpp2011128_CR68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399404008385","volume":"6","author":"MK Rowe","year":"2004","unstructured":"Rowe MK, Chuang DM (2004). Lithium neuroprotection: molecular mechanisms and clinical implications. Expert Rev Mol Med 6: 1\u201318.","journal-title":"Expert Rev Mol Med"},{"key":"BFnpp2011128_CR69","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.neubiorev.2007.03.002","volume":"31","author":"MK Rowe","year":"2007","unstructured":"Rowe MK, Wiest C, Chuang DM (2007). GSK-3 is a viable potential target for therapeutic intervention in bipolar disorder. Neurosci Biobehav Rev 31: 920\u2013931.","journal-title":"Neurosci Biobehav Rev"},{"key":"BFnpp2011128_CR70","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0168-9525(01)02625-7","volume":"18","author":"DC Rubinsztein","year":"2002","unstructured":"Rubinsztein DC (2002). Lessons from animal models of Huntington's disease. Trends Genet 18: 202\u2013209.","journal-title":"Trends Genet"},{"key":"BFnpp2011128_CR71","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1006\/bbrc.2000.4169","volume":"280","author":"WJ Ryves","year":"2001","unstructured":"Ryves WJ, Harwood AJ (2001). Lithium inhibits glycogen synthase kinase-3 by competition for magnesium. Biochem Biophys Res Commun 280: 720\u2013725.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFnpp2011128_CR72","first-page":"191","volume":"2","author":"C Sangdee","year":"1978","unstructured":"Sangdee C, Franz DN (1978). Lithium-induced enhancement of 5-HT transmission at a central synapse. Commun Psychopharmacol 2: 191\u2013198.","journal-title":"Commun Psychopharmacol"},{"key":"BFnpp2011128_CR73","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0092-8674(00)81782-1","volume":"95","author":"F Saudou","year":"1998","unstructured":"Saudou F, Finkbeiner S, Devys D, Greenberg ME (1998). Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95: 55\u201366.","journal-title":"Cell"},{"key":"BFnpp2011128_CR74","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/8.3.397","volume":"8","author":"G Schilling","year":"1999","unstructured":"Schilling G, Becher MW, Sharp AH, Jinnah HA, Duan K, Kotzuk JA et al (1999). Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin. Hum Mol Genet 8: 397\u2013407.","journal-title":"Hum Mol Genet"},{"key":"BFnpp2011128_CR75","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.biopsych.2006.06.036","volume":"62","author":"FA Schroeder","year":"2007","unstructured":"Schroeder FA, Lin CL, Crusio WE, Akbarian S (2007). Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse. Biol Psychiatry 62: 55\u201364.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2011128_CR76","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/BF02244871","volume":"116","author":"JK Shepherd","year":"1994","unstructured":"Shepherd JK, Grewal SS, Fletcher A, Bill DJ, Dourish CT (1994). Behavioural and pharmacological characterisation of the elevated \u201czero-maze\u201d as an animal model of anxiety. Psychopharmacology (Berl) 116: 56\u201364.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp2011128_CR77","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","volume":"12","author":"EJ Slow","year":"2003","unstructured":"Slow EJ, van RJ, Rogers D, Coleman SH, Graham RK, Deng Y et al (2003). Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum Mol Genet 12: 1555\u20131567.","journal-title":"Hum Mol Genet"},{"key":"BFnpp2011128_CR78","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1517\/13543784.16.12.1933","volume":"16","author":"EC Stack","year":"2007","unstructured":"Stack EC, Ferrante RJ (2007). Huntington's disease: progress and potential in the field. Expert Opin Investig Drugs 16: 1933\u20131953.","journal-title":"Expert Opin Investig Drugs"},{"key":"BFnpp2011128_CR79","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","volume":"85","author":"L Steru","year":"1985","unstructured":"Steru L, Chermat R, Thierry B, Simon P (1985). The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl) 85: 367\u2013370.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp2011128_CR80","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0168-9525(03)00074-X","volume":"19","author":"KL Sugars","year":"2003","unstructured":"Sugars KL, Rubinsztein DC (2003). Transcriptional abnormalities in Huntington disease. Trends Genet 19: 233\u2013238.","journal-title":"Trends Genet"},{"key":"BFnpp2011128_CR81","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0022-3999(02)00428-2","volume":"53","author":"S Tekin","year":"2002","unstructured":"Tekin S, Cummings JL (2002). Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update. J Psychosom Res 53: 647\u2013654.","journal-title":"J Psychosom Res"},{"key":"BFnpp2011128_CR82","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1126\/science.6269180","volume":"213","author":"SL Treiser","year":"1981","unstructured":"Treiser SL, Cascio CS, O'Donohue TL, Thoa NB, Jacobowitz DM, Kellar KJ (1981). Lithium increases serotonin release and decreases serotonin receptors in the hippocampus. Science 213: 1529\u20131531.","journal-title":"Science"},{"key":"BFnpp2011128_CR83","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.nut.2003.10.007","volume":"20","author":"A Trejo","year":"2004","unstructured":"Trejo A, Tarrats RM, Alonso ME, Boll MC, Ochoa A, Velasquez L (2004). Assessment of the nutrition status of patients with Huntington's disease. Nutrition 20: 192\u2013196.","journal-title":"Nutrition"},{"key":"BFnpp2011128_CR84","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.nbd.2006.12.010","volume":"26","author":"JM Van Raamsdonk","year":"2007","unstructured":"Van Raamsdonk JM, Metzler M, Slow E, Pearson J, Schwab C, Carroll J et al (2007). Phenotypic abnormalities in the YAC128 mouse model of Huntington disease are penetrant on multiple genetic backgrounds and modulated by strain. Neurobiol Dis 26: 189\u2013200.","journal-title":"Neurobiol Dis"},{"key":"BFnpp2011128_CR85","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1460-9568.1995.tb01057.x","volume":"7","author":"R Ventimiglia","year":"1995","unstructured":"Ventimiglia R, Mather PE, Jones BE, Lindsay RM (1995). The neurotrophins BDNF, NT-3 and NT-4\/5 promote survival and morphological and biochemical differentiation of striatal neurons in vitro. Eur J Neurosci 7: 213\u2013222.","journal-title":"Eur J Neurosci"},{"key":"BFnpp2011128_CR86","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","volume":"57","author":"JP Vonsattel","year":"1998","unstructured":"Vonsattel JP, DiFiglia M (1998). Huntington disease. J Neuropathol Exp Neurol 57: 369\u2013384.","journal-title":"J Neuropathol Exp Neurol"},{"key":"BFnpp2011128_CR87","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1212\/01.WNL.0000052992.58107.67","volume":"60","author":"VL Wheelock","year":"2003","unstructured":"Wheelock VL, Tempkin T, Marder K, Nance M, Myers RH, Zhao H et al (2003). Predictors of nursing home placement in Huntington disease. Neurology 60: 998\u20131001.","journal-title":"Neurology"},{"key":"BFnpp2011128_CR88","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/1073858405284360","volume":"12","author":"NH Woo","year":"2006","unstructured":"Woo NH, Lu B (2006). Regulation of cortical interneurons by neurotrophins: from development to cognitive disorders. Neuroscientist 12: 43\u201356.","journal-title":"Neuroscientist"},{"key":"BFnpp2011128_CR89","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0361-9230(03)00141-2","volume":"61","author":"NI Wood","year":"2003","unstructured":"Wood NI, Morton AJ (2003). Chronic lithium chloride treatment has variable effects on motor behaviour and survival of mice transgenic for the Huntington's disease mutation. Brain Res Bull 61: 375\u2013383.","journal-title":"Brain Res Bull"},{"key":"BFnpp2011128_CR90","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/emboj.2008.23","volume":"27","author":"T Yamanaka","year":"2008","unstructured":"Yamanaka T, Miyazaki H, Oyama F, Kurosawa M, Washizu C, Doi H et al (2008). Mutant Huntingtin reduces HSP70 expression through the sequestration of NF-Y transcription factor. EMBO J 27: 827\u2013839.","journal-title":"EMBO J"},{"key":"BFnpp2011128_CR91","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/sj.mp.4002099","volume":"14","author":"S Yasuda","year":"2009","unstructured":"Yasuda S, Liang MH, Marinova Z, Yahyavi A, Chuang DM (2009). The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons. Mol Psychiatry 14: 51\u201359.","journal-title":"Mol Psychiatry"},{"key":"BFnpp2011128_CR92","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.pbb.2009.08.001","volume":"94","author":"D Zadori","year":"2009","unstructured":"Zadori D, Geisz A, Vamos E, Vecsei L, Klivenyi P (2009). Valproate ameliorates the survival and the motor performance in a transgenic mouse model of Huntington's disease. Pharmacol Biochem Behav 94: 148\u2013153.","journal-title":"Pharmacol Biochem Behav"},{"key":"BFnpp2011128_CR93","doi-asserted-by":"crossref","first-page":"33067","DOI":"10.1074\/jbc.M212635200","volume":"278","author":"F Zhang","year":"2003","unstructured":"Zhang F, Phiel CJ, Spece L, Gurvich N, Klein PS (2003). Inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) in response to lithium. Evidence for autoregulation of GSK-3. J Biol Chem 278: 33067\u201333077.","journal-title":"J Biol Chem"},{"key":"BFnpp2011128_CR94","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","volume":"293","author":"C Zuccato","year":"2001","unstructured":"Zuccato C, Ciammola A, Rigamonti D, Leavitt BR, Goffredo D, Conti L et al (2001). Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease. Science 293: 493\u2013498.","journal-title":"Science"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp2011128.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2011128","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2011128.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:24:22Z","timestamp":1684455862000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp2011128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,27]]},"references-count":94,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["BFnpp2011128"],"URL":"https:\/\/doi.org\/10.1038\/npp.2011.128","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,27]]}}}